Clinical Cases in Pharmacology Clinical Cases  ·  Hematology II  ·  Coagulation  ·  Numbers That Look Like an Emergency, a Patient Who Isn't Bleeding
Hematology II, Case 0008 — Coagulation

Numbers That Look Like an Emergency, a Patient Who Isn't Bleeding

A septic patient's coagulation panel reads like a transfusion emergency, but nothing on his skin or in his output backs that up — the team has to decide whether to treat the labs or the patient.

Abbreviations, terms, and other agents mentioned in this case DIC — disseminated intravascular coagulation  ·  PT/INR — prothrombin time / international normalized ratio  ·  ISTH — International Society on Thrombosis and Haemostasis
Presentation

F.N., a 54-year-old man whose wife has been sleeping in the recliner beside his bed for two nights rather than go home, was admitted with a perforated diverticulitis and started on source-directed antibiotics and IV fluids after a CT confirmed a walled-off perforation not requiring emergent surgery. He supervises a warehouse floor of eighteen people who, by his account, have been texting his phone in relays for updates. His vital signs have stayed within normal range throughout — blood pressure holding without vasopressors, urine output adequate, a lactate that was normal at 1.4 on admission and is normal again at 0.9 today — the absence of a deterioration signal rather than evidence of a response — but this morning's labs show a platelet count of 62,000/µL, an INR of 1.9, a fibrinogen of 92 mg/dL, and a markedly elevated D-dimer, a pattern consistent with disseminated intravascular coagulation triggered by his underlying sepsis. On exam, there is no new bruising, no oozing from his IV sites, no blood in his drain output, and no mucosal bleeding of any kind — his coagulation panel describes a patient who should be bleeding, and the patient in the bed is not.

That mismatch is exactly what the team is arguing about. ISTH guidance on DIC management is explicit that prophylactic replacement of platelets, cryoprecipitate, or plasma is not recommended in the absence of active bleeding or a high-risk invasive procedure — the abnormal numbers reflect an underlying process that treating the sepsis itself should correct, and correcting the numbers directly without correcting the trigger risks obscuring the actual trend that matters, which is whether his coagulopathy improves as his infection responds to antibiotics. His fibrinogen of 92, though low, is not below the level some clinicians treat as an independent trigger for cryoprecipitate regardless of bleeding status — a threshold more commonly invoked in trauma or peripartum hemorrhage than in a source-controlled, hemodynamically stable medical patient like him.

F.N. · 54 Fibrinogen 92 mg/dL, no active bleeding
History
Perforated diverticulitis, day 2 of source-directed antibiotics, no surgery needed
Vitals
BP stable off vasopressors, adequate urine output, lactate normal throughout (1.4 → 0.9)
Platelets
62,000/µL
PT/INR
1.9
Fibrinogen
92 mg/dL
D-dimer
Markedly elevated
Bleeding exam
No bruising, no IV-site oozing, no drain blood, no mucosal bleeding
Planned procedures
None scheduled; no invasive intervention anticipated in next 24h

Rounding on hospital day 2, reading a coagulation panel against an unremarkable exam

Hematologist Opening

Nothing here meets the bar for replacement. ISTH's own DIC guidance is explicit: platelets, cryoprecipitate, and plasma are for active bleeding or an imminent high-risk procedure, neither of which applies to him right now. His actual therapy is the antibiotics already running — the coagulation panel should track his sepsis response, not get corrected independently of it.

Critical Care Physician Response

I'll push on the fibrinogen specifically — 92 is low enough that I've watched patients look exactly this stable right up until they weren't. Some protocols treat sub-100 fibrinogen as its own trigger for cryoprecipitate regardless of what the rest of the picture shows, precisely to get ahead of that kind of sudden turn.

I take the guideline point seriously, but a guideline written for the average DIC patient isn't automatically right for every individual trajectory, and this one's direction is what worries me.

Hematologist Final

I'd name where that sub-100 threshold actually comes from, though — it's largely trauma and postpartum hemorrhage literature, populations already bleeding or about to be. He isn't either. Applying a threshold built for active massive hemorrhage to a stable, source-controlled medical patient is importing the wrong comparison, not a more cautious reading of the same evidence.

What I'd agree to is close monitoring rather than prophylactic correction — repeat fibrinogen, platelets, and INR in twelve hours rather than the standard next-morning draw, so a real deteriorating trend gets caught fast, without treating today's snapshot as an emergency it isn't yet.

Regimen selected
Source-Directed Antibiotics (Continued)
Anti-Infective · Unchanged, ongoing
The actual therapy for sepsis-associated DIC; treats the trigger rather than the downstream coagulation numbers.
Repeat Coagulation Panel at 12 Hours
Monitoring · Escalated from standard once-daily
Catches a genuinely worsening trend fast, addressing the critical care physician's concern without prophylactic transfusion today.
Cryoprecipitate/FFP — Not Given Today
Blood Product · Withheld absent bleeding or a planned procedure
ISTH guidance reserves replacement for active bleeding or an imminent high-risk procedure, neither present; the sub-100 fibrinogen threshold cited derives from a different clinical population (active hemorrhage).
Where this was left

Agreed: no prophylactic transfusion today, antibiotics unchanged, repeat coagulation panel at 12 hours rather than the standard interval, and an explicit standing order that any new bleeding of any kind triggers immediate replacement without waiting for that recheck.

Educational content only — a composite teaching case, not a real patient encounter or a substitute for clinical guidance. About These Cases →